Safety, Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down Syndrome
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael S. Rafii, MD, PhD
USC Keck School of Medicine of the University of Southern California, San Diego
Study DirectorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Joseph'S Hospital and Medical Center - Barrow Neurology Clinics
Phoenix, Arizona, United States
- Ucsd Adult Down Syndrome Program
La Jolla, California, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2016
- Primary completion
- 30 Jun 2020
- Completion
- 30 Jun 2020
- Last update posted
- 15 Oct 2021
- Registered enrollment
- 20
- Registry id
- NCT02738450
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.